BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 17652382)

  • 21. Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.
    Song C; Sutton L; Johnson ME; D'Aquila RT; Donahue JP
    J Biol Chem; 2012 May; 287(20):16965-74. PubMed ID: 22451677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
    Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.
    Wurtzer S; Goubard A; Mammano F; Saragosti S; Lecossier D; Hance AJ; Clavel F
    J Virol; 2006 Apr; 80(7):3679-83. PubMed ID: 16537639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.
    Nguyen DH; Gummuluru S; Hu J
    J Virol; 2007 May; 81(9):4465-72. PubMed ID: 17314171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
    Peng G; Lei KJ; Jin W; Greenwell-Wild T; Wahl SM
    J Exp Med; 2006 Jan; 203(1):41-6. PubMed ID: 16418394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
    Han Y; Wang X; Dang Y; Zheng YH
    PLoS Pathog; 2008 Jul; 4(7):e1000095. PubMed ID: 18604271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
    Bonvin M; Greeve J
    Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
    Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
    J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unedited inhibition of HBV replication by APOBEC3G.
    Seppen J
    J Hepatol; 2004 Dec; 41(6):1068-9. PubMed ID: 15582148
    [No Abstract]   [Full Text] [Related]  

  • 30. APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication.
    Proto S; Taylor JA; Chokshi S; Navaratnam N; Naoumov NV
    Antiviral Res; 2008 Jun; 78(3):260-7. PubMed ID: 18313151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
    Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
    Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifaceted antiviral actions of APOBEC3 cytidine deaminases.
    Chiu YL; Greene WC
    Trends Immunol; 2006 Jun; 27(6):291-7. PubMed ID: 16678488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stably expressed APOBEC3F has negligible antiviral activity.
    Miyagi E; Brown CR; Opi S; Khan M; Goila-Gaur R; Kao S; Walker RC; Hirsch V; Strebel K
    J Virol; 2010 Nov; 84(21):11067-75. PubMed ID: 20702622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
    Baumert TF; Rösler C; Malim MH; von Weizsäcker F
    Hepatology; 2007 Sep; 46(3):682-9. PubMed ID: 17625792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of Alu retrotransposition by APOBEC3G.
    Hulme AE; Bogerd HP; Cullen BR; Moran JV
    Gene; 2007 Apr; 390(1-2):199-205. PubMed ID: 17079095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
    Romani B; Engelbrecht S; Glashoff RH
    Arch Virol; 2009; 154(10):1579-88. PubMed ID: 19669862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-α induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells.
    Mohanram V; Sköld AE; Bächle SM; Pathak SK; Spetz AL
    J Immunol; 2013 Apr; 190(7):3346-53. PubMed ID: 23427247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.
    Marin M; Golem S; Rose KM; Kozak SL; Kabat D
    J Virol; 2008 Jan; 82(2):987-98. PubMed ID: 17977970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro.
    Bonvin M; Greeve J
    J Gen Virol; 2007 Dec; 88(Pt 12):3270-3274. PubMed ID: 18024895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.
    Zennou V; Bieniasz PD
    Virology; 2006 May; 349(1):31-40. PubMed ID: 16460778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.